Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
The British Journal of Radiology|March 9, 2016
A comparison of two post-processing analysis methods to quantify cerebral metabolites measured via proton magnetic resonance spectroscopy in HIV diseaseJoseph Scott, Jonathan Underwood, Lucy J Garvey, et al.AIDS Research and Therapy|April 16, 2016
Evolution of changes in cognitive function after the initiation of antiretroviral therapyBorja Mora-Peris, Elizabeth Stevens, Francesca Ferretti, et al.BMJ Case Reports|February 14, 2019
Disseminated CMV infection and HLH in a patient with well-controlled HIV and ulcerative colitisBeatrice Clare Cockbain, Borja Mora Peris, Aula Abbara, et al.The Journal of Antimicrobial Chemotherapy|October 17, 2015
HIV-1 CNS in vitro infectivity models based on clinical CSF samplesBorja Mora-Peris, Alan Winston, Lucy Garvey, et al.The Journal of Antimicrobial Chemotherapy|February 1, 2013
Pharmacokinetic profile and safety of 150 mg of maraviroc dosed with 800/100 mg of darunavir/ritonavir all once daily, with and without nucleoside analogues, in HIV-infected subjectsBorja Mora-Peris, Adam Croucher, Laura J Else, et al.The Journal of Antimicrobial Chemotherapy|February 20, 2015
A Phase I study to assess the safety, tolerability and pharmacokinetic profile of boceprevir and sildenafil when dosed separately and together, in healthy male volunteersBorja Mora-Peris, Laura Else, David Goldmeier, et al.HIV Clinical Trials|March 18, 2015
The pharmacokinetic profile of raltegravir-containing antiretroviral therapy in HIV-infected individuals over 60 years of ageJaime H Vera, Akil Jackson, Laura Dickinson, et al.Journal of Neurovirology|June 6, 2020
Changes in functional connectivity in people with HIV switching antiretroviral therapySofia Toniolo, Mara Cercignani, Borja Mora-Peris, et al.HIV Medicine|May 22, 2025
HIV seroconversions and genotypic viral resistance profiles in the PrEP impact trialAndrea Cartier, Ana Milinkovic, Lisa Goodall, et al.British Journal of Clinical Pharmacology|August 22, 2025
Dolutegravir with enteral feeds in intensive care: Case series with therapeutic drug monitoringSuki Leung, Adam Temple, Yaser Al-Shakarchi, et al.Pageof 3